Patent ID: 8153693
Filing Date: 2012-04-10
Classification: A61K,A61P

Abstract:
1. A method of treatment of the immune-inflammatory component of celiac disease comprising, administering to a patient in need thereof, a therapeutically effective amount of a composition comprising a compound of formula (I) or pharmaceutically acceptable salts or esters thereof wherein R Y and Z, equal or different from each other, are selected from the group comprising —H, —OH, —COOH, OR wherein R -(±) 3-(3′-aminophenyl)-2-hydroxy-propionic acid of formula 2-(4-aminophenyl)-2-methoxyacetic acid, 2-(3-aminophenyl)-2-ethoxyacetic acid, 2-(4-aminophenyl)-2-ethoxyacetic acid, 3-(4′-aminophenyl)-2-methoxypropionic acid of formula 3-(4′-aminophenyl)-2-ethoxypropionic acid of formula 3-(3′-aminophenyl)-2-methoxypropionic acid of formula and 3-(3′ aminophenyl)-2-ethoxypropionic acid of formula